Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.54+0.00 (+0.51%)

Close on Nov 13, 2026Market cap $14.69MP/E –Yield –

Citius Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2017 it was -$9.98M.

Period	Period end	Value	Change
FY2017	Sep 30, 2017	-$9.98M	–
FY2016	Sep 30, 2016	-$7.45M	–

See a number that looks wrong?